Improvement in Gemcitabine-Induced Thrombotic Microangiopathy with Rituximab in a Patient with Ovarian Cancer: Mechanistic Considerations

Gemcitabine is a potent and widely used anticancer drug. We report a case of gemcitabine-induced thrombotic microangiopathy (GCI-TMA), a known but not widely recognized complication of gemcitabine use, and our experience of treating GCI-TMA with rituximab. A 74-year-old woman was referred to our cli...

Descripción completa

Detalles Bibliográficos
Autores principales: Murugapandian, Sangeetha, Bijin, Babitha, Mansour, Iyad, Daheshpour, Sepehr, Pillai, Biju G., Thajudeen, Bijin, Salahudeen, Abdulla K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2015
Materias:
Published online: June, 2015
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519601/
https://www.ncbi.nlm.nih.gov/pubmed/26266248
http://dx.doi.org/10.1159/000435807

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4519601/
https://www.ncbi.nlm.nih.gov/pubmed/26266248
http://dx.doi.org/10.1159/000435807

Ejemplares similares